H Wanibuchi Selected Research

H Wanibuchi Research Topics

Disease

17	Carcinogenesis 07/2004 - 01/2000
10	Neoplasms (Cancer) 07/2004 - 02/2000
5	Aberrant Crypt Foci 07/2004 - 01/2000
3	Carcinoma (Carcinomatosis) 12/2001 - 04/2000
2	Hyperplasia 01/2001 - 04/2000
1	Microsatellite Instability 12/2001
1	Carcinoma in Situ 06/2000
1	Transitional Cell Carcinoma 06/2000
1	Cystitis 06/2000
1	Papilloma (Papillomatosis) 04/2000
1	Body Weight (Weight, Body) 01/2000

Drug/Important Bio-Agent (IBA)

5	ButylhydroxybutylnitrosamineIBA 12/2001 - 01/2000
4	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 12/2001 - 01/2000
3	CarcinogensIBA 07/2004 - 01/2000
3	8-Hydroxy-2'-DeoxyguanosineIBA 07/2004 - 06/2000
3	Dimenhydrinate (DMH)FDA LinkGeneric 12/2001 - 01/2000
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2001 - 08/2000
2	Cysteine (L-Cysteine)FDA Link 01/2001 - 08/2000
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2001 - 02/2000
2	S-methylcysteineIBA 12/2000 - 08/2000
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 07/2004
1	benzocycloheptapyridineIBA 07/2004
1	NitrosaminesIBA 12/2001
1	Codon (Codons)IBA 12/2001
1	butyl(3-carboxypropyl)nitrosamineIBA 09/2001
1	nitrosobenzylmethylamineIBA 01/2001
1	Bromodeoxyuridine (BrdU)IBA 01/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2001
1	TriterpenesIBA 01/2001
1	Ethanol (Ethyl Alcohol)IBA 01/2001
1	morpholineIBA 12/2000
1	Sodium NitriteIBA 12/2000
1	Phenobarbital (Luminal)FDA Link 08/2000
1	Glutathione Transferase (Glutathione S-Transferase)IBA 08/2000
1	auraptenIBA 07/2000
1	coumaperineIBA 07/2000
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2000
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2000
1	ArsenicIBA 06/2000
1	Keratins (Keratin)IBA 06/2000
1	LactoferrinIBA 06/2000
1	Arsenicals (Arsenic Compounds)IBA 06/2000
1	Cacodylic Acid (Cacodylate)IBA 06/2000
1	MetallothioneinIBA 04/2000
1	Cyclin D1IBA 04/2000
1	SodiumIBA 04/2000
1	trimethylenediamineIBA 02/2000
1	Messenger RNA (mRNA)IBA 02/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2000
1	hydroxide ionIBA 02/2000
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2000
1	Proteins (Proteins, Gene)FDA Link 01/2000
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2000
1	Drinking WaterIBA 01/2000

Therapy/Procedure

2	Hepatectomy 01/2001 - 08/2000
1	Castration 04/2000